Document Detail

Culprit only or multivessel percutaneous coronary interventions in patients with ST-segment elevation myocardial infarction and multivessel disease.
MedLine Citation:
PMID:  22917729     Owner:  NLM     Status:  In-Data-Review    
Aims: In patients with ST-segment elevation myocardial infarction (STEMI), timely reperfusion with primary percutaneous coronary intervention (PPCI) is the preferred treatment. However, it remains unclear whether the optimal strategy is complete revascularisation or culprit vessel PPCI only. Methods and results: From January 2002 to June 2009 all patients treated with PPCI were identified from the Western Denmark Heart Registry. We examined mortality according to timing of multivessel PCI: acute procedure, staged procedure during the index hospitalisation, or staged procedure performed within 60 days. The hazard ratio (HR) for death was estimated using a time-dependent Cox regression model, with time of PCI for the non-culprit lesion as the time-dependent variable. The study cohort consisted of 5,944 patients, of whom 4,770 (80%) had single-vessel disease and 1,174 (20%) had multivessel PCI within 60 days. Among 354 (30.2%) patients with acute multivessel PCI, 194 (16.5%) patients with multivessel PCI during the index hospitalisation, and 626 (53.3%) patients with multivessel PCI within 60 days after the index hospitalisation, the adjusted HRs for one-year mortality were 1.53 (95% confidence interval (CI): 1.07-2.18), 0.60 (95% CI: 0.28-1.26), and 0.28 (95% CI: 0.14-0.54), respectively, compared to patients with single vessel disease. Conclusions: Acute multivessel PCI in patients with STEMI was associated with increased mortality.
Lisette Okkels Jensen; Per Thayssen; Dóra Körmendiné Farkas; Mikkel Hougaard; Christian Juhl Terkelsen; Hans-Henrik Tilsted; Michael Maeng; Anders Junker; Jens Flensted Lassen; Erzsébet Horváth-Puhó; Henrik Toft Sørensen; Leif Thuesen
Related Documents :
22420239 - Biomarkers of inflammation and cardiac remodeling: the quest of relevant companions for...
17804969 - Improved treatment of hospitalized coronary artery disease patients with the get with t...
17515459 - Clinical reminders attached to echocardiography reports of patients with reduced left v...
9679719 - Heterogeneous expression and activity of endothelial and inducible nitric oxide synthas...
2208819 - Management of the patient following coronary thrombolysis.
7722129 - Treatment with beta-adrenergic blocking agents after myocardial infarction: from random...
20801789 - Fc1 dipeptidyl peptidase iv inhibitors limit myocardial infarct size in a glucose-sensi...
19135029 - Effects of iron oxide nanoparticles on cardiac differentiation of embryonic stem cells.
3588449 - Hypertrophic cardiomyopathy in the adolescent.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology     Volume:  8     ISSN:  1969-6213     ISO Abbreviation:  EuroIntervention     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-08-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101251040     Medline TA:  EuroIntervention     Country:  France    
Other Details:
Languages:  eng     Pagination:  456-64     Citation Subset:  IM    
Department of Cardiology, Odense University Hospital, Odense, Denmark.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Paclitaxcel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: an ...
Next Document:  Contemporary use and outcome of percutaneous coronary interventions in patients with acute coronary ...